Wednesday, September 16, 2026

Kim Jong Un Celebrates Korean War Veterans with Mysterious Gifts

North Korean leader Kim Jong Un is raising the celebratory atmosphere ahead of the 71st "Victory Day" by sending gifts to war veterans.

Yuhan Corp., Celltrion and LigaChem Bio…K-Pharma Firms Move to Boost Corporate Value

The pharmaceutical and biotech sectors are boosting shareholder trust and corporate value through stock buybacks and retirements.

Psoriasis in Winter: Why Early Intervention is Crucial for Long-term Management

Psoriasis affects many, particularly in winter. Early treatment is vital for managing symptoms and preventing complications.

Health

Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra

Celltrion has submitted a U.S. Phase 4 trial application to support the use of a higher 240 mg dose of Zymfentra, aiming to expand personalized dosing options and strengthen the drug's position in the U.S. market.

Blood Proteins May Offer Clues to Alzheimer’s Antibody Treatment Benefits and Side-Effect Risks

A South Korean study found that blood levels of complement proteins C1q and C3 may help predict amyloid reduction and ARIA risk in patients receiving lecanemab, though larger studies are needed.

Pentrym Confirms Combination Benefits With Existing Cancer Drugs, Targets “False Resistance”

Pentrym is testing whether targeting the tumor microenvironment alongside existing cancer drugs can overcome “false resistance” and improve treatment effectiveness.

YH42946: The Promising HER2 Targeted Oral Treatment Set to Transform Cancer Care in 2026

Yuhan Corporation will reveal early results of its oral HER2-targeted therapy candidate 'YH42946' in clinical trials by year-end.

SK Biopharm Achieves MSCI ESG AAA Rating for 3rd Consecutive Year: What It Means for the Pharma Industry

SK Biopharm has achieved the highest AAA rating in MSCI's ESG evaluation for three consecutive years.
Latest

Beyond Approval to Insurance Coverage: Medical AI Companies Turn to Real-World Evidence to Drive Adoption

The focus of the medical AI industry is shifting from technology development to integration in healthcare settings.

Coreline Soft Wins German Lung Cancer Screening Project With 10-Year Long-Term Operating Contract

Coreline Soft is expanding its European AI medical imaging business through a 10-year German lung cancer screening contract, strengthening its position in the growing LDCT screening market.

Samsung Seoul, Asan Medical Center, Korea University Guro Rated Among ‘Best’ in Newsweek’s Green Hospital Ranking

Four South Korean hospitals earned Newsweek’s top five-leaf rating in its inaugural global ranking of the world’s greenest hospitals, highlighting the country’s growing focus on sustainable health care.

Unlocking Growth: How Biopharmaceuticals’ Cenobamate is Transforming Epilepsy Treatment in Asia

SK Biopharmaceuticals' epilepsy drug Cenobamate is expected to continue its growth trend in the second half of the year.

Drinking to Cope With Emotional Pain May Raise Depression Risk: “Only Harms Your Health”

Drinking to cope with trauma may worsen depression over time by weakening the brain’s ability to regulate stress.

AI to Fill Gaps in Regional and Essential Healthcare, Raising Hopes for a Major Shift in the Medical Device Market

South Korea's new AI healthcare strategy is expected to accelerate adoption of AI across public and essential healthcare, creating new growth opportunities for medical AI, healthcare IT and AI drug development companies.

How the SIALAP System Revolutionizes Preclinical Trials for Drug-Resistant Epilepsy

Researchers developed an objective framework for matching animal models to specific types of drug-resistant epilepsy, potentially improving the accuracy of preclinical drug development.

Is Your Food Safe? 5 Key Insights on Rising Salmonella and Norovirus Cases

Salmonella food poisoning has increased for five consecutive years, with nearly 10,000 cases reported last year.

Unlocking Gut Health: HP7 Probiotics vs. Postbiotics – What You Need to Know

Hy published research on its patented probiotic HP7 in the prestigious SCI journal JMB, highlighting its significance in gut health.

FDA Adjusts Drug Review Fees: Higher for New Drugs, Lower for Generics

The FDA’s 2027 fee changes lower review costs for new drugs and biosimilars while raising fees for generics and medical devices, with the impact varying by company.

GIST Develops “Alpha DTA” AI Model to Accurately Predict Drug Candidate Potency

GIST's AI model 'Alpha DTA' predicts drug-target protein binding affinity without experimental verification, enhancing drug discovery.

Shaperon Accelerates Global Commercialization of NuGel…Secures U.S. Patent, Prepares for Licensing Deal

Sharperon accelerates global commercialization of its key atopic dermatitis treatment, NuGel.

“Why Can’t Stem Cell Treatments Be Offered in Korea?”…Government Maps Out a “Korean Model of Regenerative Medicine”

The debate over stem cell therapy highlights why it's available in Japan but not in South Korea.

Yuhan Corp., Celltrion and LigaChem Bio…K-Pharma Firms Move to Boost Corporate Value

The pharmaceutical and biotech sectors are boosting shareholder trust and corporate value through stock buybacks and retirements.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.